Yes-Associated Protein 1: Role and Treatment Prospects in Orthopedic Degenerative Diseases

Wenqing Xie1,2, Wenfeng Xiao1,2, Kun Tang3

  • 1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.

Insights

The Hippo-YAP1 pathway regulates stem cells and organ size. YAP1 (Yes-associated protein 1) is implicated in osteoarthritis and osteoporosis, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • The Hippo-YAP1 signaling pathway is crucial for regulating stem cell self-renewal, organ size, and tissue regeneration.
  • YAP1 (Yes-associated protein 1) is a key transcription factor within this pathway, and its dysregulation is linked to various cancers.
  • Emerging research highlights YAP1's role in orthopedic degenerative diseases like osteoarthritis and osteoporosis.

Purpose of the Study:

  • To review the significance of YAP1 in orthopedic degenerative diseases.
  • To discuss the therapeutic potential of targeting YAP1 modulation for treating these conditions.

Main Methods:

  • Literature review of studies on YAP1 in orthopedic degenerative diseases.
  • Analysis of YAP1's role in cellular processes relevant to osteoarthritis and osteoporosis.
  • Exploration of potential therapeutic strategies targeting YAP1.

Main Results:

  • YAP1 plays a significant role in the pathogenesis of osteoarthritis and osteoporosis.
  • Dysregulation of YAP1 contributes to the progression of these degenerative conditions.
  • Targeted modulation of YAP1 presents a promising avenue for future therapeutic interventions.

Conclusions:

  • YAP1 is a critical factor in orthopedic degenerative diseases.
  • Further research into YAP1 modulation could lead to novel treatments for osteoarthritis and osteoporosis.